| ASSET | YEAR | % RETURN |
|---|---|---|
Theriva Biologics (TOVX) | 2002 | 21,284,647.35% |
TG Therapeutics (TGTX) | 2002 | 281,150.03% |
Thomson Reuters Corporation Common Shares (TRI) | 2002 | 17,685.91% |
Alto Ingredients (ALTO) | 2002 | 11,732.06% |
Arena (AREN) | 2002 | 8,298.15% |
Live Ventures (LIVE) | 2002 | 6,761.43% |
Ovintiv (OVV) | 2002 | 3,609.93% |
MEDIFAST (MED) | 2002 | 2,318.74% |
NetEase (NTES) | 2002 | 1,427.15% |
USANA Health Sciences (USNA) | 2002 | 827.21% |
Xcel Brands (XELB) | 2002 | 600% |
Caledonia Mining (CMCL) | 2002 | 576.96% |
China Yuchai International (CYD) | 2002 | 487.97% |
Hecla Mining (HL) | 2002 | 462.17% |
Sohu (SOHU) | 2002 | 442.37% |
Marker Therapeutics (MRKR) | 2002 | 412.82% |
Idaho Strategic Resources (IDR) | 2002 | 400% |
Royal Gold (RGLD) | 2002 | 390.55% |
Sleep Number (SNBR) | 2002 | 377.17% |
Clean Harbors (CLH) | 2002 | 364.48% |
Tanzanian Royalty Exploration (TRX) | 2002 | 338.71% |
Yunhong Green CTI (YHGJ) | 2002 | 325.85% |
Encore Capital (ECPG) | 2002 | 323.08% |
Ziff Davis (ZD) | 2002 | 310.34% |
Kinross Gold (KGC) | 2002 | 245.07% |